In 2009, an estimated 70,980 adults (52,810 men and 18,170 women) will be diagnosed with bladder cancer in the United States. It is estimated that 14,330 deaths (10,180 men and 4,150 women) from this disease will occur this year. Among men, bladder cancer is the fourth most common cancer and the eighth most common cause of cancer death.
For people with noninvasive/superficial urothelial carcinoma, the five-year relative survival rate (the percentage of people who survive at least five years after the cancer is detected, excluding those who die from other diseases) is 93%. Seventy-four percent (74%) of people are diagnosed with this stage. If the cancer has spread to the lymph nodes or nearby organs, the five-year survival rate is 45%. If the cancer has spread to distant parts of the body, the five-year relative survival rate is 6%.
Cancer survival statistics should be interpreted with caution. These estimates are based on data from thousands of cases of this type of cancer in the United States each year, but the actual risk for a particular individual may differ. It is not possible to tell a person how long he or she will live with bladder cancer. Because the survival statistics are measured in five-year intervals, they may not represent advances made in the treatment or diagnosis of this cancer.
Statistics adapted from the American Cancer Society's publication, Cancer Facts & Figures 2009.